Global Prosthetic Heart Valves Market to Reach $8.8 Billion by 2026
SAN FRANCISCO, June 25, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Prosthetic Heart Valves - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.
FACTS AT A GLANCE
Edition: 16; Released: January 2021
Executive Engagements: 10697
Companies: 28 - Players covered include Abbott Laboratories; Boston Scientific Corporation; Colibri Heart Valve LLC; CryoLife, Inc.; Edwards Lifesciences Corporation; JenaValve Technology, Inc.; Lepu Medical Technology Co. Ltd; LivaNova PLC; Medtronic plc; Micro Interventional Devices, Inc. and Others.
Coverage: All major geographies and key segments
Segments: Type (Transcatheter Heart Valves, Tissue Heart Valves, Mechanical Heart Valves); End-Use (Hospitals, Ambulatory Surgical Centers, and Other End-Uses)
Geographies: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Brazil; Mexico; Rest of Latin America; Middle East; Africa.
Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry
ABSTRACT-
Global Prosthetic Heart Valves Market to Reach $8.8 Billion by 2026
Prosthetic Heart Valves (PHVs) are used for the replacement of pathologic native valves in patients suffering from either valvular incompetence or stenosis, or both. Factors such as aging population and increasing number of patients diagnosed with heart valve disorders are driving demand for heart valve replacement therapies worldwide. The prosthetic heart valve space has been witnessing significant technological advances over the past several years, which are enabling manufacturers to develop highly effective, durable devices with better hemodynamics, contributing to growth in their demand. Development of durable tissue heart valves, and suture-less valves as well as anti-calcification technologies are expected to push revenues in the coming years. Regulatory approvals for advanced and new prosthetic valve development, increased government funding for research on heart valves, growing awareness about heart valve disease, and favorable reimbursement policies and wider availability of individual insurance policies are also expected to boost market growth.
Amid the COVID-19 crisis, the global market for Prosthetic Heart Valves estimated at US$6.1 Billion in the year 2020, is projected to reach a revised size of US$8.8 Billion by 2026, growing at a CAGR of 6.5% over the analysis period. Transcatheter Heart Valves, one of the segments analyzed in the report, is projected to grow at a 9.3% CAGR to reach US$5.3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Tissue Heart Valves segment is readjusted to a revised 6.3% CAGR for the next 7-year period. This segment currently accounts for a 37.5% share of the global Prosthetic Heart Valves market. Transcatheter heart valves (THVs) which are implanted through a minimally invasive surgery, would benefit from the ongoing trend towards minimally invasive surgeries worldwide. Biological/Tissue valves are mainly composed of material originating in the form of living tissue, such as porcine (pig) aortic valves, bovine (cow) pericardium-based valves, patient's autografts, and homografts (valves engrafted from other persons).
The U.S. Market is Estimated at $2.6 Billion in 2021, While China is Forecast to Reach $836.1 Million by 2026
The Prosthetic Heart Valves market in the U.S. is estimated at US$2.6 Billion in the year 2021. The country currently accounts for a 41.26% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$836.1 Million in the year 2026 trailing a CAGR of 8.5% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.3% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR while Rest of European market (as defined in the study) will reach US$906.1 Million by the end of the analysis period. The developed markets in Europe and the US have been pioneers in heart valve technologies, and have been the epicenter of significant advancements in this area. With high appetite for advanced and new products, along with high prevalence and incidence of targeted patient population, the US and Europe have been at the forefront of prosthetic heart valve usage. Japan, with its significant aging population, also represents a major market. Preference for heart valves in these markets is shifting towards biological valves, and further towards Transcatheter Heart Valves, driven mainly by favorable reimbursement environment and improved patient outcomes. Increasing prevalence of rheumatic heart disease, aging population in some markets, and growing prevalence of heart diseases in general are expected to drive growth in the Asia-Pacific market.
Mechanical Heart Valves Segment to Contract to $708.6 Million by 2026
Mechanical heart valves, the most conventional form of Prosthetic Heart Valves, continue to be used worldwide, although their use is on the decline, particularly in the developed world. Mechanical valves/mechanical prostheses are manufactured completely from man-made/synthetic material and are generally based on carbon, plastic or metal alloys. In the global Mechanical Heart Valves segment, USA, Canada, Japan, China and Europe will drive the -6.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$811.2 Million in the year 2020 will reach a projected size of US$498.1 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$69.2 Million by the year 2026, while Latin America will expand at a 0.5% CAGR through the analysis period. More
MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.
Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android
About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.
CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
Email: [email protected]
LINKS
Join Our Expert Panel
https://www.strategyr.com/Panelist.asp
Connect With Us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./
Follow Us on Twitter
https://twitter.com/marketbytes
Journalists & Media
[email protected]
SOURCE Global Industry Analysts, Inc.
Share this article